Convergent evolution and targeting of diverse E2 epitopes by human broadly neutralizing antibodies are associated with HCV clearance
Most bNAbs from chronically HCV-infected people use the VH1-69 gene segment and target the envelope glycoprotein E2 front layer. Ogega et al. isolate bNAbs from an elite neutralizer who spontaneously cleared HCV. These bNAbs use a variety of VH genes a…